Annual CFF
$1.08B$924.00M+577.50%
Summary
- Current Value
- As of today, DGX annual cash from financing is $1.08B, up +577.50% on
- Historical Performance
- DGX annual cash from financing is up +142.68% over the past 3 years, and up +381.78% over the past 5 years
- All-Time High Comparison
- DGX annual cash from financing is currently at its all-time high
- 3-Year Low Comparison
- DGX annual cash from financing is +162.59% above its 3-year low of -$1.73B reached on an earlier date
- Sector Comparison
- DGX annual cash from financing is higher than 98.98% of companies in Healthcare sector
Cash From Financing Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash From Financing | $1.08B | +577.5% | +142.7% | +381.8% | +308.0% | |
| Quarterly Cash From Financing | -$247.00M | -114.0% | +47.9% | -375.0% | +31.6% | |
| TTM Cash From Financing | -$1.27B | -191.8% | +18.3% | -2117.5% | -54.8% | |
| Price | $174.44 | +13.3% | +14.1% | +41.9% | +228.3% | |
| Annual Cash From Operations | $1.33B | +4.9% | -40.3% | +7.3% | +33.8% | |
| Annual Cash From Investing | -$2.55B | -140.2% | -10000.0% | -520.0% | -1200.6% | |
| Annual Dividends Paid | $331.00M | +5.4% | +7.1% | +15.7% | +342.8% | |
| Annual Total Debt | $7.09B | +28.9% | +48.5% | +30.9% | +128.1% | |
| Shares Outstanding | 111.24M | +0.6% | +0.2% | -16.4% | – |
Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.08B | at high | |
| 5Y | $1.08B | at high | |
| All | $1.08B | at high |
Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$1.73B | N/A | +162.6% |
| 5Y | -$2.54B | +142.7% | |
| All | -$2.54B | +142.7% |
Cash From Financing History
FAQ
What is the current annual cash from financing of DGX?
As of today, DGX annual cash from financing is $1.08B
What is 1-year change in DGX annual cash from financing?
DGX annual cash from financing is up +577.50% year-over-year
What is 3-year change in DGX annual cash from financing?
DGX annual cash from financing is up +142.68% over the past 3 years
How far is DGX annual cash from financing from its all-time high?
DGX annual cash from financing is currently at its all-time high
How does DGX annual cash from financing rank versus sector peers?
DGX annual cash from financing is higher than 98.98% of companies in Healthcare sector
When is DGX next annual earnings release?
The next annual earnings release for DGX is on
Quarterly CFF
-$247.00M$46.00M+15.70%
Summary
- Current Value
- As of today, DGX quarterly cash from financing is -$247.00M, up +15.70% on
- Historical Performance
- DGX quarterly cash from financing is down -113.95% year-over-year, and up +47.89% over the past 3 years
- All-Time High Comparison
- DGX quarterly cash from financing is currently -113.95% below its historical high of $1.77B set on
- 3-Year Low Comparison
- DGX quarterly cash from financing is +55.97% above its 3-year low of -$561.00M reached on
- Sector Comparison
- DGX quarterly cash from financing is higher than 3.91% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash From Financing | -$247.00M | +15.7% | -114.0% | +47.9% | -375.0% | |
| Annual Cash From Financing | $1.08B | – | +577.5% | +142.7% | +381.8% | |
| TTM Cash From Financing | -$1.27B | -270.4% | -191.8% | +18.3% | -2117.5% | |
| Price | $174.44 | -3.9% | +13.3% | +14.1% | +41.9% | |
| Quarterly Cash From Operations | $563.00M | +3.5% | +58.1% | +12.2% | -34.7% | |
| Quarterly Cash From Investing | -$201.00M | -62.1% | +87.7% | -70.3% | -4.2% | |
| Quarterly Dividends Paid | $89.00M | -1.1% | +6.0% | +14.1% | +17.1% | |
| Quarterly Total Debt | $6.38B | -0.0% | -8.4% | +37.5% | +23.9% | |
| Shares Outstanding | 111.24M | – | +0.6% | +0.2% | -16.4% |
Quarterly Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$170.00M | N/A | -45.3% |
| 3Y | $1.77B | -114.0% | |
| 5Y | $1.77B | -114.0% | |
| All | $1.77B | -114.0% |
Quarterly Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$561.00M | +56.0% | |
| 3Y | -$561.00M | +56.0% | |
| 5Y | -$1.57B | +84.2% | |
| All | -$1.57B | +84.2% |
Quarterly Cash From Financing History
FAQ
What is the current quarterly cash from financing of DGX?
As of today, DGX quarterly cash from financing is -$247.00M
What is DGX quarterly cash from financing most recent change?
DGX quarterly cash from financing was up +15.70% on September 30, 2025
What is 1-year change in DGX quarterly cash from financing?
DGX quarterly cash from financing is down -113.95% year-over-year
How far is DGX quarterly cash from financing from its all-time high?
DGX quarterly cash from financing is currently -113.95% below its historical high of $1.77B set on September 30, 2024
How does DGX quarterly cash from financing rank versus sector peers?
DGX quarterly cash from financing is higher than 3.91% of companies in Healthcare sector
When is DGX next earnings release?
The next earnings release for DGX is on
TTM CFF
-$1.27B$2.02B-270.38%
Summary
- Current Value
- As of today, DGX TTM cash from financing is -$1.27B, down -270.38% on
- Historical Performance
- DGX TTM cash from financing is down -191.84% year-over-year, and up +18.32% over the past 3 years
- All-Time High Comparison
- DGX TTM cash from financing is currently -191.84% below its historical high of $1.38B set on
- 3-Year Low Comparison
- DGX TTM cash from financing is +26.62% above its 3-year low of -$1.73B reached on an earlier date
- Sector Comparison
- DGX TTM cash from financing is higher than 3.63% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM Cash From Financing | -$1.27B | -270.4% | -191.8% | +18.3% | -2117.5% | |
| Annual Cash From Financing | $1.08B | – | +577.5% | +142.7% | +381.8% | |
| Quarterly Cash From Financing | -$247.00M | +15.7% | -114.0% | +47.9% | -375.0% | |
| Price | $174.44 | -3.9% | +13.3% | +14.1% | +41.9% | |
| TTM Cash From Operations | $1.89B | +12.3% | +34.9% | +1.1% | +4.0% | |
| TTM Cash From Investing | -$942.00M | +60.3% | +56.4% | -58.0% | -33.8% | |
| TTM Dividends Paid | $347.00M | +1.5% | +6.1% | +13.0% | +18.4% | |
| Quarterly Total Debt | $6.38B | -0.0% | -8.4% | +37.5% | +23.9% | |
| Shares Outstanding | 111.24M | – | +0.6% | +0.2% | -16.4% |
TTM Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.08B | N/A | -217.3% |
| 3Y | $1.38B | -191.8% | |
| 5Y | $1.38B | -191.8% | |
| All | $1.38B | -191.8% |
TTM Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$1.27B | at low | |
| 3Y | -$1.73B | N/A | +26.6% |
| 5Y | -$3.01B | +57.7% | |
| All | -$3.01B | +57.7% |
TTM Cash From Financing History
FAQ
What is the current TTM cash from financing of DGX?
As of today, DGX TTM cash from financing is -$1.27B
What is DGX TTM cash from financing most recent change?
DGX TTM cash from financing was down -270.38% on September 30, 2025
What is 1-year change in DGX TTM cash from financing?
DGX TTM cash from financing is down -191.84% year-over-year
How far is DGX TTM cash from financing from its all-time high?
DGX TTM cash from financing is currently -191.84% below its historical high of $1.38B set on September 30, 2024
How does DGX TTM cash from financing rank versus sector peers?
DGX TTM cash from financing is higher than 3.63% of companies in Healthcare sector
When is DGX next earnings release?
The next earnings release for DGX is on
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
Data Sources & References
- DGX Official Website www.questdiagnostics.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1022079/000102207925000218/0001022079-25-000218-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1022079/000102207925000044/0001022079-25-000044-index.htm
- DGX Profile on Yahoo Finance finance.yahoo.com/quote/DGX
- DGX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dgx